医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program.

广告
第一作者: Roberto,Giugliani
第一单位: Dep Genetics UFRGS, Casa dos Raros, INAGEMP, Med Genet Serv HCPA, and DASA Genomics, Porto Alegre, Brazil. rgiugliani@hcpa.edu.br.
作者单位: Dep Genetics UFRGS, Casa dos Raros, INAGEMP, Med Genet Serv HCPA, and DASA Genomics, Porto Alegre, Brazil. rgiugliani@hcpa.edu.br. [1] Hospital Universitario Virgen del Rocio, Seville, Spain. [2] Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, Udine, Italy. [3] Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. [4] University of California Irvine School of Medicine, Children's Health of Orange County, Orange, CA, USA. [5] Centro Hospitalar Universitário de Santo António, Porto, Portugal. [6] Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. [7] University Medical Center Mainz, Villa Metabolica, Mainz, Germany. [8] Centre Hospitalier Universitaire La Timone, Marseille, France. [9] Children's National Hospital, Washington, District of Columbia, USA. [10] Seattle Children's Hospital, Seattle, WA, USA. [11] Laboratorio Chamoles, Buenos Aires, Argentina. [12] Ultragenyx Pharmaceutical Inc, Novato, CA, USA. [13]
DOI 10.1186/s13023-024-03176-z
PMID 38715031
发布时间 2026-05-14
基金项目
Ultragenyx Pharmaceutical/
提交
  • 浏览3
Orphanet journal of rare diseases

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷